Literature DB >> 13925040

Non-functional bronchial carcinoid tumours.

P S VASSAR, C F CULLING.   

Abstract

Entities:  

Keywords:  ADENOMA/case reports; BRONCHI/neoplasms; SEROTONIN/metabolism

Mesh:

Substances:

Year:  1962        PMID: 13925040      PMCID: PMC1849489     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  Adenomatoid bronchial tumors. A consideration of the carcinoid tumors and the salivary tumors of the bronchial tree.

Authors:  L WEISS; M INGRAM
Journal:  Cancer       Date:  1961 Jan-Feb       Impact factor: 6.860

2.  Tumours of the lung and the carcinoid syndrome.

Authors:  E D WILLIAMS; J G AZZOPARDI
Journal:  Thorax       Date:  1960-03       Impact factor: 9.139

3.  A new color reaction for tryptamine derivatives. Histochemical application to enterochromaffin cells.

Authors:  J HOLCENBERG; E P BENDITT
Journal:  Lab Invest       Date:  1961 Jan-Feb       Impact factor: 5.662

4.  Desoxyribose nucleic acid. A fluorescent histochemical technique.

Authors:  C CULLING; P VASSAR
Journal:  Arch Pathol       Date:  1961-01

5.  The nonbenign nature of bronchial carcinoids and cylindromas.

Authors:  J T GOODNER; J W BERG; W L WATSON
Journal:  Cancer       Date:  1961 May-Jun       Impact factor: 6.860

6.  Simultaneous duodenal carcinoid and non-beta cell tumors of the pancreas. Two tumors of high ulcerogenic potential.

Authors:  B C GERBER; T W SHIELDS
Journal:  Arch Surg       Date:  1960-09

7.  5-Hydroxytryptophan-secreting bronchial carcinoid tumour.

Authors:  M SANDLER; P J SCHEUER; P J WAT
Journal:  Lancet       Date:  1961-11-11       Impact factor: 79.321

8.  Immunological study in the Zollinger-Ellison syndrome.

Authors:  A P MONACO; J P LYTHGOE; W R WADDELL
Journal:  Lancet       Date:  1961-11-04       Impact factor: 79.321

9.  On the concentration of 5-hydroxytryptamine in mammalian enterochromaffin cells and its release by reserpine.

Authors:  E P BENDITT; R L WONG
Journal:  J Exp Med       Date:  1957-06-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.